Notes to Consolidated financial Consol_Note39

39 Expenditure incurred on Research and Development

( In Crore)

Particulars

For the year ended 31 March

2024

2023

   

a.

Revenue expenditure – charged to Statement of Profit and Loss

527.38

500.05

b.

Revenue expenditure – capitalised

c.

Capital expenditure – excluding building

36.89

37.56

d.

Capital expenditure – building

564.27

537.61